Chemesis International Inc. Provides Corporate Update
Chemesis International Inc. Provides Corporate Update
December 9, 2019
Vancouver, BC – Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or
“Chemesis”), announces, further to its news release dated November 1, 2019, that certain of the cannabis
licenses (“Licenses”) held by its subsidiary, Natural Ventures PR, LLC (“ Natural Ventures”), remain subject to
the administrative review (“Review”) being undertaken by the Puerto Rico Department of Health, and that the
Company has now taken the step of instructing its Puerto Rico legal team to apply to the Puerto Rico Superior
Court, San Juan, for an order establishing that the Puerto Rico Department of Health’s actions in regard to the
Review are not consistent with the legal and regulatory framework applicable to the Licenses (“ Court
Application”). The Company will provide further updates as appropriate.
The Company notes that at the current time the Licenses effectively remain in abeyance, as Natural Ventures
is not permitted to carry out any licensed activities under the Licenses, though it is permitted to carry out
certain activities for the purposes of preserving and maintaining inventory.
On Behalf of The Board of Directors
Edgar Montero
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated U.S. Multi-State operator with International operations in Puerto
Rico and Colombia.
The Company focuses on prudent capital allocation to ensure it maintains a first mover advantage as it enters new
markets and is committed to differentiate itself by deploying resources in markets with major opportunities. The
Company operates a portfolio of brands that cater to a wide community of cannabis consumers, with focus on quality
and consistency.
Chemesis has facilities in both Puerto Rico and California. The Company is positioned to win additional licenses in
highly competitive merit-based US states and will expand its footprint to ensure it maintains a first mover advantage.
Investor Relations:
1 (604) 398-3378
Forward-Looking Information: This news release contains "forward-looking information" within the meaning of applicable
securities laws relating to statements regarding the Company's business, products and future of the Company’s business, its
product offerings and plans for sales and marketing, including with r espect to the Company’s expectations regarding its supply
and distribution arrangements, ability to realize benefits from its recent contractual arrangements, its plans to continue to
develop dispensaries in Puerto Rico, and its ability to obtain licenses in additional jurisdictions. Although the Company believes
that the expectations reflected in the forward -looking information are reasonable, there can be no assurance that such
expectations will prove to be correct. Readers are cautioned not to place und ue reliance on forward -looking information. Such
forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments
to differ materially from those contemplated by these statements depending on, am ong other things, the risks that the
Company's products and plan will vary from those stated in this news release and the Company may not be able to carry out its
business plans as expected, including, but not limited to, in relation to executing on and ma intaining its supply and distribution
arrangements and recent contractual arrangements, in relation to developing dispensaries in Puerto Rico, and its ability to obtain
licenses in additional jurisdictions. Except as required by law, the Company expressly disclaims any obligation and does not intend
to update any forward-looking statements or forward-looking information in this news release. Although the Company believes
that the expectations reflected in the forward -looking information are reasonable, ther e can be no assurance that such
expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news
release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release